Olaratumab May Be Safe and Effective in Patients With Advanced Soft Tissue Sarcoma

The researchers conducted a retrospective cohort study of patients with advanced STS treated at a single institution over a 12 month period.

from Latest articles from Cancer Therapy Advisor News https://ift.tt/2UCVoBl